uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted July 01, 2005

FDA Issues Nationwide Alert for "Liqiang 4" Due to Potential Health Risk

On July 1, 2005, the U.S. Food and Drug Administration (FDA) warned consumers not to take Liqiang 4 Dietary Supplement Capsules because they contain glyburide – a drug that could have serious, life-threatening consequences in some people.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at